Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03497767
Title A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (OUTRUN)
Acronym OUTRUN
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trans Tasman Radiation Oncology Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Calvary Mater Newcastle New South Wales 2298 Australia Details
Liverpool Hospital Sydney New South Wales 2002 Australia Details
St. Vincents Hospital Sydney New South Wales 2010 Australia Details
Westmead Hospital Sydney New South Wales 2145 Australia Details
Blacktown Hospital Sydney New South Wales 2148 Australia Details
St George Hospital Sydney New South Wales 2217 Australia Details
Princess Alexandra Hospital Brisbane Queensland 4102 Australia Details
ICON Cancer Centre Greenslopes Brisbane Queensland 4120 Australia Details
Royal Adelaide Hospital Adelaide South Australia Australia Details
Peter MacCallum Cancer Center Melbourne Victoria 3002 Australia Details
Monash Health Melbourne Victoria 3175 Australia Details
Sir Charles Gairdner Perth Western Australia Australia Details
National University Hospital Singapore 119074 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field